Brain Tumor Treatment in India: A Complete Guide for Patients from Bangladesh

Author:- Dr. Dheeraj Bojwani Date Created:- 05-08-2026

A brain tumor diagnosis rarely needs just one specialist. It typically needs a neurosurgeon, a neuropathologist to grade the tumour under a microscope, and often a radiation oncologist for follow-up therapy — all working from the same imaging and coordinating the same plan. A 2025 review of Bangladesh's neurological health landscape found that specialised neurological care remains concentrated in a small number of tertiary centres, mostly in Dhaka, with inadequate healthcare infrastructure and a shortage of specialists especially outside the capital. For many Bangladeshi families, the real challenge is not finding one skilled surgeon — it is finding every specialist a brain tumour diagnosis requires, coordinating with each other, in one place. This guide sets out what brain tumor treatment in India actually involves, what it realistically costs compared with the UK and US, and the practical decisions that separate a smooth trip from a stressful one.

Healing Journeys of Bangladeshi Patients

Bangladeshi Patients Share Their Experience

Key Takeaways

• The guide explains that brain tumor treatment can be complex for Bangladeshi patients, as specialised neurological and neuro-oncology care remains concentrated in a limited number of tertiary centres. Finding a coordinated team of neurosurgery, neuropathology and radiation oncology specialists is therefore an important part of treatment planning.
• The guide highlights the importance of identifying the tumour type, location and WHO grade before deciding on treatment. Depending on the diagnosis, patients may require surgery, conventional radiotherapy, Gamma Knife or CyberKnife radiosurgery, chemotherapy or targeted therapy, with molecular and genetic testing helping guide additional treatment decisions.
• Multidisciplinary tumour-board review is a key consideration when choosing a treatment centre in India. Bangladeshi patients should confirm that the case will be reviewed by a neurosurgeon, neuro-oncologist, radiation oncologist and neuropathologist rather than being managed by the operating surgeon alone.
• The guide recommends that patients begin treatment planning before travelling to India. MRI or CT scans can be reviewed remotely, followed by a written cost estimate, hospital confirmation, medical-visa arrangements and an in-person consultation with further imaging or biopsy if required.
• Treatment costs vary according to the tumour and treatment required. The guide gives an illustrative range of US$15,000–35,000 in India, compared with approximately US$60,000–120,000 in the UK and US$150,000–400,000+ in the US. Pathology, molecular testing, chemotherapy and long-term follow-up may involve additional costs.
• Patients should compare complete treatment packages rather than surgery prices alone. Before travelling, they should confirm whether the quotation covers surgery, neuropathology, molecular testing, radiotherapy sessions, ICU and hospital stay, and understand what additional treatment may be required after pathology results.
• The guide recommends planning the entire treatment and recovery journey, with surgery alone generally requiring around four weeks away from home and treatment involving radiotherapy potentially extending the stay to six weeks or more. Patients should also decide whether radiotherapy will be completed in India or continued in Bangladesh.
• Bangladeshi patients should also arrange post-treatment follow-up before returning home. The Indian team can provide a written MRI schedule and treatment summary for continued care in Bangladesh, with video follow-up and communication between the Indian and Bangladeshi medical teams where appropriate.

Quick Facts

Treatment

Brain Tumor Treatment

Country

India

Patients

Bangladeshi Patients

Key Specialists

Neurosurgeon, Neuropathologist & Radiation Oncologist

Treatment Options

Surgery, Radiotherapy, Radiosurgery & Systemic Therapy

Key Assessment

Tumor Type, Location, WHO Grade & Molecular Profile

Advanced Technologies

Gamma Knife & CyberKnife

Key Requirement

Multidisciplinary Tumour Board

India Cost

US$15,000–35,000

UK Cost

US$60,000–120,000

US Cost

US$150,000–400,000+

Surgery Stay

Approximately 7–10 Days

Overall Stay

About 4 Weeks for Surgery; 6+ Weeks With Radiotherapy

Pre-Travel Planning

MRI/CT Review & Written Estimate

Visa

Indian Medical Visa

Follow-Up

MRI Monitoring & Continued Care in Bangladesh

Key Financial Check

Itemised Treatment Estimate

Warning Sign

Treatment Planned Without Multidisciplinary Review

Author

Dr. Dheeraj Bojwani

Experience

24+ Years

In Brief

Brain tumor treatment in India for Bangladeshi patients may involve surgery, radiotherapy, radiosurgery, chemotherapy or targeted therapy depending on the tumour's type, location and grade. The guide recommends choosing a centre with coordinated multidisciplinary neuro-oncology care, molecular testing capabilities and appropriate radiotherapy technology. Patients should obtain a detailed written estimate, arrange medical-visa documentation before travel and establish a clear plan for continued treatment and MRI follow-up in Bangladesh.

What Brain Tumor Treatment Actually Involves

Not all brain tumours are treated the same way, and the plan depends on whether the tumour is benign or malignant, its location, and its grade under the World Health Organization's classification system. Treatment generally draws on:

• Surgery (craniotomy or endoscopic resection) — removing as much of the tumour as can be done safely, sometimes using awake craniotomy and intraoperative mapping when the tumour sits near speech or movement centres.
• Radiotherapy — including conventional fractionated radiotherapy delivered over several weeks, or focused single-or few-session techniques such as Gamma Knife or CyberKnife radiosurgery for smaller, well-defined tumours.
• Chemotherapy and targeted therapy — used for specific malignant tumour types, guided by molecular and genetic testing of the tumour tissue removed during surgery.
• Multidisciplinary tumour board review — where a neurosurgeon, neuro-oncologist, radiation oncologist and neuropathologist jointly review the case, rather than one specialist deciding in isolation.

Ask specifically whether the tumour is benign or malignant, its WHO grade, and whether the treatment plan has been reviewed by a full multidisciplinary team rather than by the operating surgeon alone.

Why the Regional Care Gap Matters for Treatment Planning

Because specialised neurological and neuro-oncology capacity in Bangladesh is concentrated in a handful of centres, a brain tumour diagnosis outside Dhaka can mean travelling repeatedly between a surgeon, a separate radiotherapy centre, and a pathology lab, often without any of them formally coordinating as a team. This has a direct planning consequence: a fragmented pathway, where surgery happens in one place and radiotherapy decisions are made later and separately, risks delay and gaps in follow-up exactly when consistency matters most. It also means that finding a centre that offers surgery, pathology and radiotherapy under one coordinated plan is worth more than finding the single most famous surgeon.

Why India Specifically for Brain Tumor Treatment?

India has become a common destination for Bangladeshi patients seeking neuro-oncology treatment abroad. Peer-reviewed research surveying patients directly at the Indian Visa Application Centre in Chittagong found that the decision consistently comes down to a combination of experienced specialist teams, hospital quality and cost, rather than any single factor. Several practical advantages reinforce this pattern for brain tumour treatment specifically:

• Integrated multidisciplinary tumour boards in larger centres in Kolkata, Chennai, Delhi and Mumbai, where a neurosurgeon, neuro-oncologist, radiation oncologist and neuropathologist review each case together rather than in isolation.
• Access to advanced radiotherapy technology, including Gamma Knife and CyberKnife radiosurgery, alongside conventional surgery, under one roof.
• Molecular and genetic tumour testing, which increasingly determines whether chemotherapy or targeted therapy will genuinely benefit a specific patient.
• Easy connectivity and an established medical-visa system built specifically around Bangladeshi patients, including a dedicated government portal for hospital invitation letters and provision for up to three accompanying attendants.

What the Numbers Actually Mean

The headline number matters less than what it includes. A Bangladeshi patient comparing quotes should ask each Indian hospital to confirm whether the figure covers surgery, neuropathology and molecular testing, the number of radiotherapy sessions if needed, the full ICU and hospital stay rather than just the operating theatre fee, and the follow-up MRI schedule. Chemotherapy or targeted therapy, when indicated by molecular testing, is almost always a separate, ongoing cost.

Peer-reviewed research on cross-border medical travel found that international patients spend an average of 3,800 to 7,000 US dollars per visit once transport, accommodation and incidental costs are added to treatment itself — a range worth budgeting for on top of the treatment cost shown above. How long a patient stays in India depends heavily on whether radiotherapy is completed there or continued at home: surgery alone typically needs 20 to 28 days away; a full radiotherapy course added on can extend this to six weeks or more.

Most Bangladeshi patients follow a broadly similar sequence, whether they travel independently or through a medical-facilitation service. Knowing the shape of it in advance makes each step easier to plan for.

Factors a Bangladeshi Patient Should Weigh Before Brain Tumor Treatment in India

Beyond the surgery itself, the decisions that most affect a patient's experience are logistical and financial rather than purely medical. Consider each of the following before confirming a hospital:

• Which city, not just which hospital. Kolkata is closest and most familiar linguistically; Chennai, Delhi and Mumbai often have a wider choice of integrated neuro-oncology centres. Weigh travel time and cost against the depth of the care team.
• A genuine multidisciplinary tumour board — not the operating surgeon's case volume alone. Ask directly whether a neuro-oncologist, radiation oncologist and neuropathologist all review the case together.
• Genuine hospital accreditation. Ask whether the hospital holds NABH or JCI accreditation and verify it directly through the accreditation board's own directory rather than taking a brochure's word for it.
• An itemised, written estimate covering surgery, pathology and molecular testing, the number of radiotherapy sessions, and what happens financially if additional therapy is needed after the pathology results return.
• Medical visa documentation. A formal invitation letter from the treating hospital, submitted through India's official medical-visa channel, is required at the Indian visa centre in Dhaka, Chittagong, Sylhet or Rajshahi.
• A travel companion. Indian hospitals generally expect at least one attendant to stay with the patient; factor their stay, food and local transport into the budget.
• A written plan for whether radiotherapy is completed in India or continued in Bangladesh, and who coordinates the handover between the two teams.
• Follow-up access. Ask whether the surgeon offers video follow-up consultations, and what the long-term schedule is for repeat MRI scans to monitor for recurrence.

Before You Book: A Checklist for Brain Tumor Treatment in India

A Closing Words

For most Bangladeshi families, India offers a genuine value proposition for brain tumor treatment: an integrated team — surgeon, neuropathologist and radiation oncologist working from one coordinated plan — at a fraction of the cost charged in the UK or US. The value, however, depends entirely on the specifics: confirmation that a full multidisciplinary team, not one surgeon, has reviewed the case, a transparent itemised estimate, and a realistic plan for where treatment continues once the patient is back home. Patients who ask detailed questions before booking, rather than after arriving, consistently report a smoother experience — medically and financially.

Sources

• 🌐 National Medical Commission of India — statutory body for verifying a doctor's registration and specialist qualifications. · nmc.org.in
• 🌐 National Accreditation Board for Hospitals & Healthcare Providers (NABH) — India's principal healthcare accreditation authority, under the Quality Council of India. · nabh.co
• 🌐 The Current Situation of Neurological Health in Bangladesh: A Perspective. Peer-reviewed review, hosted via NIH/NCBI, on specialist availability and infrastructure gaps in Bangladeshi neurological care. · pmc.ncbi.nlm.nih.gov/articles/PMC11872797
• 🌐 Determinants of Bangladeshi patients' decision-making process and satisfaction toward medical tourism in India. Peer-reviewed study, hosted via NIH/NCBI. · pmc.ncbi.nlm.nih.gov/articles/PMC10185743
• 🌐 Government of India — Medical Value Travel / e-Medical Visa Portal, Bureau of Immigration, Ministry of Home Affairs — official channel for hospital invitation letters and medical-visa provisions for Bangladeshi nationals. · indianfrro.gov.in/frro/medicalvaluetravel

Frequently Asked Questions by Bangladeshi Patients about Brain Tumor Treatment in India

What brain tumor treatments are available in India?

Treatment may include surgery, conventional radiotherapy, Gamma Knife or CyberKnife radiosurgery, chemotherapy and targeted therapy. The appropriate combination depends on the tumour's characteristics.

How much does brain tumor treatment cost in India?

The guide gives an indicative range of US$15,000–35,000 for complete treatment involving surgery and radiotherapy where indicated. Additional therapies and long-term follow-up may cost extra.

Why is a multidisciplinary tumour board important?

A tumour board allows neurosurgeons, neuro-oncologists, radiation oncologists and neuropathologists to review the case together. This can help create a coordinated treatment plan instead of decisions being made by one specialist alone.

Is molecular testing important for brain tumors?

For certain malignant tumours, molecular and genetic testing can help determine the need for chemotherapy or targeted therapy. The guide recommends confirming whether appropriate tumour testing is included in the treatment plan.

How long should Bangladeshi patients stay in India?

For surgery alone, the guide suggests roughly four weeks away from home. If a radiotherapy course is added, the stay may extend to six weeks or more.

Can radiotherapy be continued in Bangladesh?

Often, yes. The guide recommends discussing in advance whether radiotherapy will be completed in India or continued after returning to Bangladesh, with proper coordination between both medical teams.

What should be included in a treatment quotation?

Patients should check whether the quotation covers surgery, pathology, molecular testing, radiotherapy sessions, ICU and hospital stay, and the planned follow-up MRI schedule.

Do Bangladeshi patients need a medical visa?

Yes. The guide states that patients travelling for treatment should use the appropriate medical-visa process, supported by an invitation letter from the treating Indian hospital.

Can follow-up scans be done in Bangladesh?

Yes. The Indian team can provide a written MRI and treatment follow-up schedule for a doctor in Bangladesh, with periodic communication or video consultations where appropriate.

What should patients check before choosing an Indian hospital?

Patients should check multidisciplinary expertise, tumour-board review, accreditation, molecular testing, radiotherapy capabilities, transparent costs and arrangements for follow-up after returning to Bangladesh.

Page Summary

This guide helps Bangladeshi patients understand and plan brain tumor treatment in India, covering surgery, radiotherapy, radiosurgery, molecular testing and multidisciplinary care. It explains how to evaluate treatment centres, compare indicative costs of US$15,000–35,000 in India, plan the medical-visa and travel process, and understand the expected treatment timeline. The guide also stresses the importance of tumour-board review, itemised treatment estimates and a clear follow-up plan in Bangladesh, particularly when radiotherapy or further treatment is required after surgery.

Citation Block

Field	Information
Topic	Brain Tumor Treatment in India
Treatment	Brain Tumor Surgery, Radiotherapy, Radiosurgery & Systemic Therapy
Country	India
Patients	Bangladeshi Patients
Key Specialists	Neurosurgeon, Neuropathologist & Radiation Oncologist
Treatment Selection	Tumour Type, Location, WHO Grade and Molecular Profile
Surgical Options	Craniotomy, Endoscopic Resection and Selected Awake Surgery
Radiotherapy Options	Conventional Radiotherapy, Gamma Knife and CyberKnife
Molecular Testing	Genetic and Molecular Tumour Testing
Multidisciplinary Care	Neurosurgery, Neuro-Oncology, Radiation Oncology and Neuropathology
Tumour Board	Recommended for Coordinated Treatment Planning
Hospital Quality	NABH / JCI Accreditation
India Cost	US$15,000–35,000
UK Cost	US$60,000–120,000
US Cost	US$150,000–400,000+
Surgery Stay	Approximately 7–10 Days
Overall Treatment Stay	Approximately 4 Weeks for Surgery; 6+ Weeks With Radiotherapy
Pre-Travel Assessment	MRI / CT Review and Further Imaging or Biopsy if Required
Cost Components	Surgery, Neuropathology, Molecular Testing, Radiotherapy and Hospital Stay
Travel Planning	Medical Visa, Hospital Invitation Letter and Travel Companion
Follow-Up	MRI Schedule and Continued Treatment Coordination in Bangladesh
Radiotherapy Planning	Decide Whether Treatment Is Completed in India or Bangladesh
Communication	Video Follow-Up and Handover Between Indian and Bangladeshi Teams
Family Planning	Travel Companion, Accommodation and Extended Treatment Stay
Key Selection Factor	Integrated Neuro-Oncology Team Rather Than Surgeon Alone
Warning Sign	Fragmented Care or Treatment Without Multidisciplinary Review